rxstat › Shortages › Rupatadine

Rupatadine (Rupall) shortage status

Shortage anticipated

Source: Health Canada shortage reports · Updated Sep 14, 2026

A shortage of Rupatadine is anticipated but not yet confirmed. 1 product(s) have anticipated-shortage reports on file with Health Canada.

An antihistamine used to relieve allergy symptoms such as hay fever and hives.

Products affected
0 / 2
Reports on file
2

Shortage history

2026

Shortage history (red bands = periods in shortage).

Reports by product

The DIN is printed on your prescription label.

Anticipated
RUPALL
1MG · SOLUTION · MEDEXUS PHARMACEUTICALS INC.
DIN 02456478 · Delay in shipping of the drug.
Resolved
APO-RUPATADINE
10MG · TABLET · APOTEX INC
DIN 02553155 · ended Dec 18, 2025 · Disruption of the manufacture of the drug.

What's happening

A manufacturer has told Health Canada it expects supply of Rupatadine to fall short of demand. Anticipated shortages sometimes resolve without patients noticing; this page updates as soon as the status changes.

Rupatadine is classified under “ANTIHISTAMINES FOR SYSTEMIC USE” (ATC R06AX).

Recent changes

Common questions

What is Rupatadine used for?

An antihistamine used to relieve allergy symptoms such as hay fever and hives.

When will Rupatadine be back in stock in Canada?

Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.

Why is Rupatadine in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Possible alternatives in the same class (antihistamines for systemic use)

Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.

Dimenhydrinate (Gravol) No current shortage Loratadine No current shortage Bilastine Partial shortage 1 of 2 reported products affected · est. return Sep 30, 2026 Cetirizine (Extra Strength Allergy Relief) Partial shortage 1 of 15 reported products affected Diphenhydramine (Unisom Sleepgels Extra Strength) Partial shortage 2 of 9 reported products affected Doxylamine Pyridoxine Partial shortage 1 of 2 reported products affected

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.